OUP user menu

Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling

(CC)
Alexander Schulz, Anna Kyselyova, Stephan L. Baader, Marie Juliane Jung, Ansgar Zoch, Victor-Felix Mautner, Christian Hagel, Helen Morrison
DOI: http://dx.doi.org/10.1093/brain/awt327 420-432 First published online: 5 December 2013

Summary

Axonal surface proteins encompass a group of heterogeneous molecules, which exert a variety of different functions in the highly interdependent relationship between axons and Schwann cells. We recently revealed that the tumour suppressor protein merlin, mutated in the hereditary tumour syndrome neurofibromatosis type 2, impacts significantly on axon structure maintenance in the peripheral nervous system. We now report on a role of neuronal merlin in the regulation of the axonal surface protein neuregulin 1 important for modulating Schwann cell differentiation and myelination. Specifically, neuregulin 1 type III expression is reduced in sciatic nerve tissue of neuron-specific knockout animals as well as in biopsies from seven patients with neurofibromatosis type 2. In vitro experiments performed on both the P19 neuronal cell line and primary dorsal root ganglion cells demonstrate the influence of merlin on neuregulin 1 type III expression. Moreover, expression of ERBB2, a Schwann cell receptor for neuregulin 1 ligands is increased in nerve tissue of both neuron-specific merlin knockout animals and patients with neurofibromatosis type 2, demonstrating for the first time that axonal merlin indirectly regulates Schwann cell behaviour. Collectively, we have identified that neuronally expressed merlin can influence Schwann cell activity in a cell-extrinsic manner.

  • axon
  • merlin
  • myelination
  • neuregulin 1
  • neurofibromatosis type 2
  • polyneuropathy
  • Schwann cell
  • Abbreviation
    NF2
    neurofibromatosis type 2
  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

    View Full Text